Vaccines : the new bivalent Moderna still not recommended
The first bivalent booster vaccine, COVID-19, is approved by the UK drug regulator. Analysis and comments by Jean-Marc Sabatier based on information provided by the manufacturer.
The first bivalent booster vaccine, COVID-19, is approved by the UK drug regulator. Analysis and comments by Jean-Marc Sabatier based on information provided by the manufacturer.
Due to the new opinion of the European Medicines Agency and the Epi-Phare report confirming the risk of myocarditis and pericarditis, the French National Authority for Health (Haute Autorité de Santé) advises against the Moderna vaccine for certain segments of the population.